Here’s what the GHK-Cu sources can tell us.
A long reading list can look like a mountain of proof. These sources do different jobs. Some explain why researchers are interested; others describe a small human study or an FDA concern. Here’s how we use them.
Lab work
Where the interest began.
The collagen experiment found that human skin cells in a dish made more collagen with GHK-Cu, without an increase in cell number. It didn’t test a face cream on people. That leaves a gap between an interesting cell response and a visible skin benefit.
The gene-activity review discusses cell research and gene-data comparisons. It doesn’t show people becoming younger. The rat study of free GHK examined its breakdown in rats, without establishing a human GHK-Cu schedule. Those setting and ingredient details belong beside the findings whenever we mention them.
These papers help explain ideas worth investigating. They can’t answer a personal question about what a cream or an injection will do.
Skin & hair
What was actually applied or measured?
The skin review reports cosmetic findings from earlier work. The topical-delivery review discusses the challenge of getting through the skin barrier. They bring work together; they aren’t extra trials of a product. The skin-sample study measured copper, without proving intact GHK-Cu reached a target in a person.
The post-laser trial, completed by 13 people, found greater satisfaction without significantly faster fading of redness or improvement in measured wrinkles. The human hair trial tested a GHK blend, without copper. The follicle experiment used AHK-Cu outside the body. Similar names can hide very different experiments, so we keep the preparation in each account.
The skin page and hair page explain these results in more detail. Neither page treats a laboratory finding as proof of a benefit in people.
FDA pages
Rules, concerns and reporting.
FDA’s compounding safety page, current as of April 22, 2026, lists injectable GHK-Cu as nominated but withdrawn. Its safety concerns remain there. The page gives no date for that withdrawal. Withdrawal is not clearance or approval.
FDA’s compounded-drug explanation explains the lack of FDA approval. Its wrinkle-treatment page separates appearance claims from claims to change skin structure. MedWatch is the safety-reporting route on our contact page. These pages explain different questions from the ones a clinical trial asks.
Every source linked in the guide is listed here. For a particular claim, its link on the page takes you to the supporting source. The words around that link explain what we’re drawing from it.